Skip to main content
Premium Trial:

Request an Annual Quote

Fluidigm Receives CIA Venture Funding to Develop Microfluidics for DNA Detection

NEW YORK, Nov. 23 (GenomeWeb News) - Fluidigm has received funding from a CIA-funded venture group to develop new microfluidics technology for DNA detection, the company said yesterday.


In-Q-Tel, the not-for-profit venture group, will pay South San Francisco-based Fluidigm upfront and milestone fees and make an equity investment in the company. The funding will help Fluidigm to develop its integrated fluidic circuits technology, which can be used to collect and analyze DNA sequence information.


Fluidigm plans to develop two different IFC architectures, one that improves detection sensitivity, and another one that will enable users to detect specific sequences with high confidence using less sample.

The Scan

NFTs for Genome Sharing

Nature News writes that non-fungible tokens could be a way for people to profit from sharing genomic data.

Wastewater Warning System

Time magazine writes that cities and college campuses are monitoring sewage for SARS-CoV-2, an approach officials hope lasts beyond COVID-19.

Networks to Boost Surveillance

Scientific American writes that new organizations and networks aim to improve the ability of developing countries to conduct SARS-CoV-2 genomic surveillance.

Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool

In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.